Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MANE

+ Watchlist+ Portfolio

Veradermics, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$125.64
52-Week Range
$32.00 – $156.63
Market Cap
$5.27B
P/E (TTM)
—
EPS (TTM)
-3.89
Dividend Yield
0.00%
Advanced Metrics
Price/Book
6.61
PEG Ratio
—
Return on Equity
-23.12%
Return on Assets
-16.83%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
77.68
Debt/Equity
0.00
Total Debt
$371.00K
Free Cash Flow
$-55.22M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$4.47B

Market Snapshot

About

Veradermics, Inc. is a dermatology therapeutics company focused on developing treatments for skin conditions. The company works on novel pharmaceutical solutions for dermatological disorders. Veradermics aims to address unmet needs in the dermatology market.